Our results have also shown S100A9 expression was significantly elevated in serum samples from cirrhosis patients compared to healthy donors, as well as a significant reduction in liver samples from CCl4- or BDL-treated TRPM8−/− mice. This evidence concerns the gene S100A9 and Cirrhosis.